Web-based physical activity promotion in young people with CF: a randomised controlled trial.


Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
01 2023
Historique:
received: 11 01 2022
accepted: 13 09 2022
pubmed: 1 10 2022
medline: 7 1 2023
entrez: 30 9 2022
Statut: ppublish

Résumé

Physical activity levels are known to decline following hospitalisation for people with cystic fibrosis (pwCF). However, optimal physical activity promotion strategies are unclear. This study investigated the effect of a web-based application (ActivOnline) in promoting physical activity in young pwCF. Multicentre randomised controlled trial with assessor blinding and qualitative evaluation. People with CF (12-35 years) admitted to hospital for a respiratory cause were eligible and randomised to the 12-week ActivOnline intervention (AO) or usual care (UC). The primary outcome was change in device-based time spent in moderate-to-vigorous physical activity (MVPA) from baseline to post-intervention. Follow-up was at 6 months from hospital discharge when qualitative evaluation was undertaken. 107 participants were randomised to AO (n=52) or UC (n=55). Sixty-three participants (59%) contributed to the intention-to-treat analysis. Mean (SD) age was 21 (6) years (n=46, <18 years). At baseline, physical activity levels were high in both groups (AO 102 (52) vs UC 127 (73) min/day). There was no statistically significant difference in MVPA between groups at either timepoint (post-intervention mean difference (95% CI) -14 mins (-45 to 16)). Uptake of the intervention was low with only 40% (n=21) of participants accessing the web application. A web-based application, including individualised goal setting, real-time feedback and motivation for behavioural change, was no better than usual care at promoting physical activity in young pwCF following hospital discharge. High levels of baseline physical activity levels in both groups, and limited engagement with the intervention, suggest alternative strategies may be necessary to identify and support young pwCF who would benefit from enhanced physical activity. ACTRN12617001009303, 13 July 13 2017.

Sections du résumé

BACKGROUND
Physical activity levels are known to decline following hospitalisation for people with cystic fibrosis (pwCF). However, optimal physical activity promotion strategies are unclear. This study investigated the effect of a web-based application (ActivOnline) in promoting physical activity in young pwCF.
METHODS
Multicentre randomised controlled trial with assessor blinding and qualitative evaluation. People with CF (12-35 years) admitted to hospital for a respiratory cause were eligible and randomised to the 12-week ActivOnline intervention (AO) or usual care (UC). The primary outcome was change in device-based time spent in moderate-to-vigorous physical activity (MVPA) from baseline to post-intervention. Follow-up was at 6 months from hospital discharge when qualitative evaluation was undertaken.
RESULTS
107 participants were randomised to AO (n=52) or UC (n=55). Sixty-three participants (59%) contributed to the intention-to-treat analysis. Mean (SD) age was 21 (6) years (n=46, <18 years). At baseline, physical activity levels were high in both groups (AO 102 (52) vs UC 127 (73) min/day). There was no statistically significant difference in MVPA between groups at either timepoint (post-intervention mean difference (95% CI) -14 mins (-45 to 16)). Uptake of the intervention was low with only 40% (n=21) of participants accessing the web application.
CONCLUSION
A web-based application, including individualised goal setting, real-time feedback and motivation for behavioural change, was no better than usual care at promoting physical activity in young pwCF following hospital discharge. High levels of baseline physical activity levels in both groups, and limited engagement with the intervention, suggest alternative strategies may be necessary to identify and support young pwCF who would benefit from enhanced physical activity.
TRIAL REGISTRATION NUMBER
ACTRN12617001009303, 13 July 13 2017.

Identifiants

pubmed: 36180067
pii: thorax-2022-218702
doi: 10.1136/thorax-2022-218702
doi:

Banques de données

ANZCTR
['ACTRN12617001009303']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-23

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: NSC, AEH, KM, MM, PO’H and CAW were all named investigators on the grant which provided funding for this study.

Auteurs

Narelle S Cox (NS)

Respiratory Research@Alfred, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia narelle.cox@monash.edu.
Institute for Breathing and Sleep, Melbourne, Victoria, Australia.

Beverley Eldridge (B)

College of Science, Health and Engineering, La Trobe University, Melbourne, Victoria, Australia.
Children's Medical Research Institute, Melbourne, Victoria, Australia.

Sarah Rawlings (S)

Respiratory Research@Alfred, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.
Monash Health, Melbourne, Victoria, Australia.

Julianna Dreger (J)

Respiratory Research@Alfred, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.

Jennifer Corda (J)

Physiotherapy, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Jennifer Hauser (J)

Tasmanian Adult CF Service, Royal Hobart Hospital, Hobart, Tasmania, Australia.

Brenda M Button (BM)

Physiotherapy, Alfred Health, Melbourne, Victoria, Australia.
Allergy, Immunology and Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
Faculty of Medicine, Monash University, Melbourne, Victoria, Australia.

Jennifer R Bishop (JR)

Respiratory Medicine, Westmead Hospital, Sydney, New South Wales, Australia.

Amanda Nichols (A)

Monash Health, Melbourne, Victoria, Australia.

Anna Middleton (A)

Physiotherapy, Sydney Children's Hospital Network Westmead, Sydney, New South Wales, Australia.

Nathan Ward (N)

Physiotherapy, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Tiffany Dwyer (T)

Discipline of Physiotherapy, Sydney School of Health Sciences, University of Sydney, Sydney, New South Wales, Australia.
Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Ruth Dentice (R)

Physiotherapy, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Raynuka Lazarus (R)

Respiratory Medicine, Westmead Hospital, Sydney, New South Wales, Australia.

Paul O'Halloran (P)

College of Science, Health and Engineering, La Trobe University, Melbourne, Victoria, Australia.

Joanna Y T Lee (JYT)

Respiratory Research@Alfred, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.

Christie Mellerick (C)

Respiratory Research@Alfred, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.

Kelly Mackintosh (K)

College of Engineering, Swansea University, Swansea, UK.

Melitta McNarry (M)

College of Engineering, Swansea University, Swansea, UK.

Craig Anthony Williams (CA)

Children's Health and Exercise Research Centre, University of Exeter, Exeter, UK.

Anne E Holland (AE)

Respiratory Research@Alfred, Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia.
Institute for Breathing and Sleep, Melbourne, Victoria, Australia.
Physiotherapy, Alfred Health, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH